Results 41 to 50 of about 19,092,512 (177)

Chemical reactions of vitamin C with intravenous-iron formulations [PDF]

open access: yesNephrology Dialysis Transplantation, 2007
Intravenous (IV) iron is widely prescribed for patients on haemodialysis, to replace iron losses during treatment. It releases labile iron, which can induce oxidation of vitamin C and trigger oxidant damage. We examined the stability of vitamin C in the presence of IV iron compounds.
Suxin, Wang   +4 more
openaire   +2 more sources

Vitamin C Intervention for Critical COVID-19: A Pragmatic Review of the Current Level of Evidence

open access: yesLife, 2021
Severe respiratory infections are characterized by elevated inflammation and generation of reactive oxygen species (ROS) which may lead to a decrease in antioxidants such as vitamin C and a higher requirement for the vitamin.
Patrick Holford   +3 more
doaj   +1 more source

The relationship between COVID-19 and blood vitamin C; a systematic review study [PDF]

open access: yesJournal of Preventive Epidemiology, 2021
Introduction: The rapid worldwide spread of COVID-19 has caused a global health crisis. Unfortunately, no vaccine or special antiviral drug has been developed against COVID-19 to date, symptomatic supportive care has been the most common treatment ...
Sadeq Hosseinpour   +7 more
doaj   +1 more source

Ascorbic acid concentrations in aqueous humor after systemic vitamin C supplementation in patients with cataract: pilot study

open access: yesBMC Ophthalmology, 2017
Background To measure ascorbic acid concentration in aqueous humor of patients with cataract after oral or intravenous vitamin C supplementation. Methods Forty-two eyes of 42 patients with senile cataract who underwent uncomplicated cataract surgery were
Young-Sool Hah   +7 more
doaj   +1 more source

Evaluation of the effect of high dose intravenous vitamin C on delayed allograft function in deceased donor kidney transplantation: a preliminary report

open access: yesRenal Replacement Therapy, 2020
Background Delayed graft function (DGF) can affect short- and long-term allograft outcomes in kidney transplant recipients. One of the pathophysiological pathways in the occurrence of DGF is ischemia-reperfusion injury (IRI).
Mina Borran   +4 more
doaj   +1 more source

Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K-1) in severe acute liver disease [PDF]

open access: yes, 2005
Background/Aims: In patients with severe acute liver dysfunction, i.v. phylloquinone (vitamin K-1) may be given to exclude vitamin K deficiency, rather than impaired hepatic synthesis of coagulation factors alone, as the cause of the coagulopathy ...
Pereira, SP   +13 more
core   +1 more source

Early high-dose vitamin C in post-cardiac arrest syndrome (VITaCCA): study protocol for a randomized, double-blind, multi-center, placebo-controlled trial

open access: yesTrials, 2021
Background High-dose intravenous vitamin C directly scavenges and decreases the production of harmful reactive oxygen species (ROS) generated during ischemia/reperfusion after a cardiac arrest.
Sander Rozemeijer   +13 more
doaj   +1 more source

Intravenously administered vitamin C as cancer therapy: three cases [PDF]

open access: yesCanadian Medical Association Journal, 2006
Early clinical studies showed that high-dose vitamin C, given by intravenous and oral routes, may improve symptoms and prolong life in patients with terminal cancer. Double-blind placebo-controlled studies of oral vitamin C therapy showed no benefit.
Sebastian J, Padayatty   +5 more
openaire   +2 more sources

Vitamin C and K3 Combination Causes Enhanced Anticancer Activity against RT-4 Bladder Cancer Cells [PDF]

open access: yes, 2013
Introduction: Vitamin C (VC), Vitamin K3 (VK3) and the combination (VC:VK3) were evaluated against human bladder cancer cell lines RT-4 and T24 to evaluate their synergistic anticancer activity.
Gilloteaux, Jacques   +3 more
core   +1 more source

No significant benefit of moderate-dose vitamin C on severe COVID-19 cases

open access: yesOpen Medicine, 2021
There is no specific drug for coronavirus disease 2019 (COVID-19). We aimed to investigate the possible clinical efficacy of moderate-dose vitamin C infusion among inpatients with severe COVID-19.
Zheng Shaoping   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy